Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in the United States, Finland, and internationally. The company offers intraocular pressure measuring devices, retinal imaging equipment, perimeters, as well as software solutions under the iCare brand. Its product portfolio includes iCare IC100, IC200, ST500, TONOVET Pro, and TONOVET Plus tonometers; iCare HOME2, a home intraocular pressure monitor; and iCare Sensors, an accessories for iCare tonometers that are used for safe, painless, and hygienic intraocular pressure (IOP) measurement. Further, the company offers iCare EIDON AF, EIDON, and EIDON UWF F fundus imaging systems; iCare DRSplus; and iCare COMPASS, a device used to examine the field of vision and take confocal fundus images with accurate colours. In addition, the company provides iCare ILLUME, a device that helps to detect the early signs of diabetic retinopathy (DR), macular degeneration (AMD), and glaucoma with the help of artificial intelligence; iCare CLINIC, a cloud service that stores long-term intraocular pressure data and provides tools for versatile data analysis and reporting; and Oculo, an eye care software platform, which combines clinical communication, telehealth, remote patient monitoring and data analytics capabilities. Revenio Group Oyj was incorporated in 2001 and is based in Vantaa, Finland.